The results resemble the situation in Western countries at a time when PSA-based mass screening was not used routinely [18, 19] which indicated that PSA-based mass screening was able to detect most still organ-confined and potentially curable prostate cancer patients and to improve survival. Here, KLK3 is linked to prostate carcinoma.